Clinical characteristics of intermediate uveitis in adults according to criteria of the SUN working group.
Intermediate uveitis
Multiple sclerosis
Non-pars planitis
Pars planitis
SUN classification
Journal
International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
25
03
2023
accepted:
22
06
2023
medline:
18
9
2023
pubmed:
3
7
2023
entrez:
3
7
2023
Statut:
ppublish
Résumé
To analyse the clinical characteristics of adult patients with pars planitis (PP-IU), non-pars planitis (NPP-IU) and multiple sclerosis-associated intermediate uveitis (MS-IU) and distinguish between groups. Seventy-three adult patients with intermediate uveitis (IU) reviewed retrospectively and divided as PP-IU, NPP-IU and MS-IU according to 'The standardization of uveitis nomenclature working group classification criteria.' Demographic and clinical characteristics, OCT and fluorescein angiography (FA) findings, complications and treatments were recorded. A total of 134 eyes of 73 patients were included, and 42 of the patients were classified as PP-IU, 12 as NPP-IU, and 19 as MS-IU. If a patient presenting with blurred vision, or tent-shaped vitreous band/snowballs/snowbank on examination, or vascular leakage on FA and accompanying neurological symptoms, the frequency of demyelinating plaque detection on cranial MRI and the risk of MS-IU increased. Mean BCVA was increased from 0.22 ± 0.30 logMAR to 0.19 ± 0.31 logMAR (p = 0.021). Gender, initial BCVA, snowbank formation, disc oedema and periphlebitis on examination, and disc leakage/occlusion on FA were found predictive of decreased BCVA at final visit (p < 0.05). The clinical features of these three groups are similar, some features that can guide the differential diagnosis. It may be recommended to periodically evaluate "suspicious" patients with MRI for MS.
Identifiants
pubmed: 37395903
doi: 10.1007/s10792-023-02778-z
pii: 10.1007/s10792-023-02778-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3681-3693Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Bloch-Michel E, Nussenblatt RB (1987) International Uveitis study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 103(2):234–235
doi: 10.1016/S0002-9394(14)74235-7
pubmed: 3812627
Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of Uveitis Nomenclature Working G: Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140(3):509–516
doi: 10.1016/j.ajo.2005.03.057
pubmed: 16196117
Standardization of uveitis nomenclature working G: Development of Classification Criteria for the Uveitides. Am J Ophthalmol 2021, 228:96–105
Donaldson MJ, Pulido JS, Herman DC, Diehl N, Hodge D (2007) Pars planitis: a 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol 144(6):812–817
doi: 10.1016/j.ajo.2007.08.023
pubmed: 18036872
Sancho L, Kramer M, Koriat A, Eiger-Moscovich M, Sharon Y, Amer R (2019) Complications in intermediate uveitis: prevalence, time of onset, and effects on vision in short-term and long-term follow-up. Ocul Immunol Inflamm 27(3):447–455
doi: 10.1080/09273948.2017.1420203
pubmed: 29370567
Touhami S, Leclercq M, Stanescu-Segall D, Touitou V, Bodaghi B (2021) Differential diagnosis of vitritis in adult patients. Ocul Immunol Inflamm 29(4):786–795
doi: 10.1080/09273948.2021.1898001
pubmed: 34003716
Shoughy SS, Kozak I, Tabbara KF (2016) Associations of systemic diseases with intermediate uveitis. Ophthalmic Epidemiol 23(1):27–31
doi: 10.3109/09286586.2015.1119286
pubmed: 26786193
Vitale ATZM, Foster CS (2002) Diagnosis and treatment of uveitis. In: Foster CSVA (ed) Intermediate Uveitis. W.B.Saunders and Company, Philadelphia, pp 844–857
Ness T, Boehringer D, Heinzelmann S (2017) Intermediate uveitis: pattern of etiology, complications, treatment and outcome in a tertiary academic center. Orphanet J Rare Dis 12(1):81
doi: 10.1186/s13023-017-0638-9
pubmed: 28449695
pmcid: 5408401
Vadboncoeur J, Biernacki K, Prat A, Jaworski L (2016) Multiple sclerosis-associated uveitis. Exp Rev Ophthalmol 12(1):57–67
doi: 10.1080/17469899.2017.1264875
Abraham A, Nicholson L, Dick A, Rice C, Atan D (2021) Intermediate uveitis associated with MS: diagnosis, clinical features, pathogenic mechanisms, and recommendations for management. Neurol Neuroimmunol Neuroinflamm 8(1):e909
doi: 10.1212/NXI.0000000000000909
pubmed: 33127747
Casselman P, Cassiman C, Casteels I, Schauwvlieghe PP (2021) Insights into multiple sclerosis-associated uveitis: a scoping review. Acta Ophthalmol 99(6):592–603
doi: 10.1111/aos.14697
pubmed: 33326162
Zein G, Berta A, Foster CS (2004) Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm 12(2):137–142
doi: 10.1080/09273940490895344
pubmed: 15512983
Stamenkovic M, Obradovic D (2011) Retinal periphlebitis in patients with multiple sclerosis. Vojnosanit Pregl 68(7):544–549
doi: 10.2298/VSP1107544S
pubmed: 21899173
Standardization of uveitis nomenclature working G: classification criteria for multiple sclerosis-associated intermediate uveitis. Am J Ophthalmol 2021, 228: 72–79.
Standardization of Uveitis Nomenclature Working G: Classification Criteria for Intermediate Uveitis, Non-Pars Planitis Type. Am J Ophthalmol 2021, 228:159–164.
Standardization of Uveitis Nomenclature Working G: Classification Criteria For Pars Planitis. Am J Ophthalmol 2021, 228:268–274.
Babu BM, Rathinam SR (2010) Intermediate uveitis. Indian J Ophthalmol 58(1):21–27
doi: 10.4103/0301-4738.58469
pubmed: 20029143
Chan CK, Wu ZH, Luk FO, Liu DT, Fan AH, Lee VY, Lai TY (2013) Clinical characteristics of intermediate uveitis in Chinese patients. Ocul Immunol Inflamm 21(1):71–76
doi: 10.3109/09273948.2012.736587
pubmed: 23323585
Heinz C, Schoonbrood S, Heiligenhaus A (2014) Intermediate uveitis in children and young adults: differences in clinical course, associations and visual outcome. Br J Ophthalmol 98(8):1107–1111
doi: 10.1136/bjophthalmol-2013-304589
pubmed: 24713505
Paroli MP, Abicca I, Sapia A, Bruschi S, Pivetti Pezzi P (2014) Intermediate uveitis: comparison between childhood-onset and adult-onset disease. Eur J Ophthalmol 24(1):94–100
doi: 10.5301/ejo.5000336
pubmed: 23813110
Khairallah M, Hmidi K, Attia S, Jelliti B, Hasnaoui W, Zaouali S, Jenzeri S, Yahia SB, Messaoud R (2010) Clinical characteristics of intermediate uveitis in Tunisian patients. Int Ophthalmol 30(5):531–537
doi: 10.1007/s10792-010-9352-5
pubmed: 20204460
Ozdal PC, Berker N, Tugal-Tutkun I (2015) Pars planitis: epidemiology, clinical characteristics, management and visual prognosis. J Ophthalmic Vis Res 10(4):469–480
doi: 10.4103/2008-322X.176897
pubmed: 27051493
pmcid: 4795398
Güngör S, Akova, Y (2015) Clinical characteristics of patients with intermediate Uveitis. TJO 44 (1)
Kardes E, Sezgin Akcay BI, Bozkurt K, Unlu C, Erdogan G, Akcali G (2015) Clinical characteristics of intermediate uveitis in adult Turkish patients. Int J Ophthalmol 8(4):759–763
pubmed: 26309876
pmcid: 4539621
Messenger W, Hildebrandt L, Mackensen F, Suhler E, Becker M, Rosenbaum JT (2015) Characterisation of uveitis in association with multiple sclerosis. Br J Ophthalmol 99(2):205–209
doi: 10.1136/bjophthalmol-2014-305518
pubmed: 25170065
AlBloushi AF, Dheyab AM, Al-Swaina NF, Al-Obailan M, Daif AK, Abu El-Asrar AM (2021) Clinical findings and outcomes of uveitis associated with multiple sclerosis. Eur J Ophthalmol 31(2):482–490
doi: 10.1177/1120672120904667
pubmed: 32019337
Niederer RL, Sharief L, Bar A, Lightman SL, Tomkins-Netzer O (2017) Predictors of long-term visual outcome in intermediate uveitis. Ophthalmology 124(3):393–398
doi: 10.1016/j.ophtha.2016.11.013
pubmed: 28017424
Nusenblatt RBWS (2010) Intermediate uveitis. Uveitis: fundamentals and clinical practice. Elsevier, Chicago, pp 269–277
Tomkins-Netzer O, Lightman SL, Burke AE, Sugar EA, Lim LL, Jaffe GJ, Altaweel MM, Kempen JH, Holbrook JT, Jabs DA et al (2021) Seven-year outcomes of uveitic macular edema: the multicenter uveitis steroid treatment trial and follow-up study results. Ophthalmology 128(5):719–728
doi: 10.1016/j.ophtha.2020.08.035
pubmed: 32918964
Malinowski SM, Pulido JS, Goeken NE, Brown CK, Folk JC (1993) The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis. Ophthalmology 100(8):1199–1205
doi: 10.1016/S0161-6420(93)31505-8
pubmed: 8341502
Petrushkin H, Kidd D, Pavesio C (2015) Intermediate uveitis and multiple sclerosis: to scan or not to scan. Br J Ophthalmol 99(12):1591–1593
doi: 10.1136/bjophthalmol-2015-307269
pubmed: 26338960
Malinowski SM, Pulido JS, Folk JC (1993) Long-term visual outcome and complications associated with pars planitis. Ophthalmology 100(6):818–824
doi: 10.1016/S0161-6420(93)31567-8
pubmed: 8510893
Kim MK, Kim US (2016) Analysis of fundus photography and fluorescein angiography in nonarteritic anterior ischemic optic neuropathy and optic neuritis. Korean J Ophthalmol 30(4):289–294
doi: 10.3341/kjo.2016.30.4.289
pubmed: 27478356
pmcid: 4965604
Zierhut M, Foster CS (1992) Multiple sclerosis, sarcoidosis and other diseases in patients with pars planitis. Dev Ophthalmol 23:41–47
doi: 10.1159/000429628
pubmed: 1309708
Sicotte NL, Voskuhl RR (2001) Onset of multiple sclerosis associated with anti-TNF therapy. Neurology 57(10):1885–1888
doi: 10.1212/WNL.57.10.1885
pubmed: 11723281
Ozdemir HB, Ozdal PC (2022) Clinical characteristics and treatment of pars planitis: an adalimumab experience. Graefes Arch Clin Exp Ophthalmol 260(2):561–569
doi: 10.1007/s00417-021-05398-4
pubmed: 34568953
Cunningham ET Jr, Pavesio CE, Goldstein DA, Forooghian F, Zierhut M (2017) Multiple Sclerosis-Associated Uveitis. Ocul Immunol Inflamm 25(3):299–301
doi: 10.1080/09273948.2017.1334469
pubmed: 28696171
Abasolo L, Prieto-Garcia A, Diaz-Valle D, Benitez-Del-Castillo JM, Pato E, Garcia-Feijoo J, Fernandez-Gutierrez B, Rodriguez-Rodriguez L (2016) Influence of baseline demographic and clinical characteristics in the visual outcome of intermediate uveitis: a survival analysis. Br J Ophthalmol 100(12):1651–1655
doi: 10.1136/bjophthalmol-2015-307774
pubmed: 27030281
Malalis JF, Bhat P, Shapiro M, Goldstein DA (2017) Retinoschisis in Pars Planitis. Ocul Immunol Inflamm 25(3):344–348
doi: 10.3109/09273948.2015.1125511
pubmed: 26902143
Sizmaz S, Gungor SG, Bayar SA, Yilmaz G, Akkoyun I (2012) Laser photocoagulation in intermediate uveitis associated with retinoschisis. Ocul Immunol Inflamm 20(5):372–374
doi: 10.3109/09273948.2012.704116
pubmed: 22827157
Parchand S, Tandan M, Gupta V, Gupta A (2011) Intermediate uveitis in Indian population. J Ophthalmic Inflamm Infect 1(2):65–70
doi: 10.1007/s12348-011-0020-3
pubmed: 21484178
pmcid: 3102854
Jalil A, Dhawahir-Scala FE, Jones NP (2010) Nonprogressive tractional inferior retinal elevation in intermediate uveitis. Ocul Immunol Inflamm 18(1):60–63
doi: 10.3109/09273940903315784
pubmed: 20128653